Roche Cytovene I.V. shortage lengthens
Executive Summary
Roche expects "intermittent complete out-of-stock situations" for Cytovene I.V. to continue until the middle of the second quarter. "Despite the implementation of a system to manage the available stock, demand exceeds our ability to supply" ganciclovir, a Feb. 6 "Dear Doctor" letter says. Roche had expected to resolve the shortage of the CMV retinitis product by the second quarter (1"The Pink Sheet" Jan. 14, p. 19)....